Original Research Online Publishing Date: | ||||||||||||||||||||||||||||||
Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies Jayeeta Bhadra, Shiba Ansari, Meena Singh.
|
How to Cite this Article |
Pubmed Style Bhadra J, Ansari S, Singh M. Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. Int J Med Rev Case Rep. 2023; 7(4): 67-70. doi:10.5455/IJMRCR.172-1673369494 Web Style Bhadra J, Ansari S, Singh M. Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. https://www.mdpub.net/?mno=138301 [Access: May 31, 2024]. doi:10.5455/IJMRCR.172-1673369494 AMA (American Medical Association) Style Bhadra J, Ansari S, Singh M. Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. Int J Med Rev Case Rep. 2023; 7(4): 67-70. doi:10.5455/IJMRCR.172-1673369494 Vancouver/ICMJE Style Bhadra J, Ansari S, Singh M. Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. Int J Med Rev Case Rep. (2023), [cited May 31, 2024]; 7(4): 67-70. doi:10.5455/IJMRCR.172-1673369494 Harvard Style Bhadra, J., Ansari, . S. & Singh, . M. (2023) Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. Int J Med Rev Case Rep, 7 (4), 67-70. doi:10.5455/IJMRCR.172-1673369494 Turabian Style Bhadra, Jayeeta, Shiba Ansari, and Meena Singh. 2023. Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. International Journal of Medical Reviews and Case Reports, 7 (4), 67-70. doi:10.5455/IJMRCR.172-1673369494 Chicago Style Bhadra, Jayeeta, Shiba Ansari, and Meena Singh. "Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies." International Journal of Medical Reviews and Case Reports 7 (2023), 67-70. doi:10.5455/IJMRCR.172-1673369494 MLA (The Modern Language Association) Style Bhadra, Jayeeta, Shiba Ansari, and Meena Singh. "Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies." International Journal of Medical Reviews and Case Reports 7.4 (2023), 67-70. Print. doi:10.5455/IJMRCR.172-1673369494 APA (American Psychological Association) Style Bhadra, J., Ansari, . S. & Singh, . M. (2023) Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. International Journal of Medical Reviews and Case Reports, 7 (4), 67-70. doi:10.5455/IJMRCR.172-1673369494 |